ATE240727T1 - Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen - Google Patents

Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Info

Publication number: ATE240727T1
Authority: AT; Austria
Prior art keywords: lesions; medication; producing; composition containing; topical treatment
Prior art date: 1994-03-02

Application number

AT94912176T

Other languages

English (en)

Inventor

Bruce A Jack

B Thomas White

Original Assignee

Professional Pharmaceutical In

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-02

Filing date

1994-03-02

Publication date

2003-06-15

1994-03-02 Application filed by Professional Pharmaceutical In filed Critical Professional Pharmaceutical In

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE240727T1 publication Critical patent/ATE240727T1/de

Links

230000003902 lesion Effects 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
229960001660 histamine phosphate Drugs 0.000 title 1
ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 title 1
230000004054 inflammatory process Effects 0.000 title 1
230000000699 topical effect Effects 0.000 title 1
208000002205 allergic conjunctivitis Diseases 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
201000006082 Chickenpox Diseases 0.000 abstract 1
206010010744 Conjunctivitis allergic Diseases 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
206010018258 Giant papillary conjunctivitis Diseases 0.000 abstract 1
208000001688 Herpes Genitalis Diseases 0.000 abstract 1
208000004898 Herpes Labialis Diseases 0.000 abstract 1
208000007514 Herpes zoster Diseases 0.000 abstract 1
206010067152 Oral herpes Diseases 0.000 abstract 1
208000004210 Pressure Ulcer Diseases 0.000 abstract 1
206010042496 Sunburn Diseases 0.000 abstract 1
206010053615 Thermal burn Diseases 0.000 abstract 1
206010046980 Varicella Diseases 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
208000002399 aphthous stomatitis Diseases 0.000 abstract 1
208000024998 atopic conjunctivitis Diseases 0.000 abstract 1
238000002512 chemotherapy Methods 0.000 abstract 1
239000002270 dispersing agent Substances 0.000 abstract 1
201000004946 genital herpes Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000003265 stomatitis Diseases 0.000 abstract 1
229920002554 vinyl polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT94912176T 1994-03-02 1994-03-02 Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen ATE240727T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1994/002282 WO1995023601A1 (en)	1994-03-02	1994-03-02	Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient

Publications (1)

Publication Number	Publication Date
ATE240727T1 true ATE240727T1 (de)	2003-06-15

Family

ID=22242315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94912176T ATE240727T1 (de)	1994-03-02	1994-03-02	Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Country Status (9)

Country	Link
EP (1)	EP0706394B1 (de)
JP (1)	JP3552168B2 (de)
AT (1)	ATE240727T1 (de)
CA (1)	CA2160779C (de)
DE (1)	DE69432703T2 (de)
DK (1)	DK0706394T3 (de)
ES (1)	ES2199961T3 (de)
PT (1)	PT706394E (de)
WO (1)	WO1995023601A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6270781B1 (en) *	1999-01-08	2001-08-07	Maxim Pharmaceuticals, Inc.	Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
ATE273704T1 (de)	1999-06-03	2004-09-15	Maxim Pharm Inc	Ophthalmische histamin-enthaltende zusammensetzungen und deren verwendung
KR20040095250A (ko) *	2002-03-29	2004-11-12	맥심 파마수티컬즈 인크.	안내 손상의 치료 및 예방에 사용하기 위한 활성 산소대사물(ｒｏｍ)의 생성 및 방출 억제제의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3898325A (en) *	1973-09-19	1975-08-05	American Lipids Corp	Method and preparations for relieving pain and producing analgesia
US4228176A (en) *	1979-04-09	1980-10-14	Nelson Research & Development Company	Thromboxane inhibition with burimamide
CA1163561A (en) *	1979-11-06	1984-03-13	Cyril Boroda	Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4618490A (en) *	1980-06-06	1986-10-21	Marco Peter T De	Method of treatment of animal and human tissues damaged by burns and frank visible gangrene
US4966892A (en) *	1982-05-07	1990-10-30	Carrington Laboratories, Inc.	Processes for preparation of aloe products products produced thereby and compositions thereof
US4705685A (en) *	1982-05-17	1987-11-10	Mcmichael John	Methods and materials for treatment of disease states involving immunological factors
US5176912A (en) *	1991-01-29	1993-01-05	Orestes Cabezas	Method of treating psoriasis

1994
- 1994-03-02 EP EP94912176A patent/EP0706394B1/de not_active Expired - Lifetime
- 1994-03-02 JP JP52287495A patent/JP3552168B2/ja not_active Expired - Fee Related
- 1994-03-02 AT AT94912176T patent/ATE240727T1/de not_active IP Right Cessation
- 1994-03-02 ES ES94912176T patent/ES2199961T3/es not_active Expired - Lifetime
- 1994-03-02 CA CA002160779A patent/CA2160779C/en not_active Expired - Fee Related
- 1994-03-02 DE DE69432703T patent/DE69432703T2/de not_active Expired - Fee Related
- 1994-03-02 DK DK94912176T patent/DK0706394T3/da active
- 1994-03-02 PT PT94912176T patent/PT706394E/pt unknown
- 1994-03-02 WO PCT/US1994/002282 patent/WO1995023601A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP0706394A1 (de)	1996-04-17
JPH08509994A (ja)	1996-10-22
PT706394E (pt)	2003-10-31
WO1995023601A1 (en)	1995-09-08
CA2160779C (en)	2008-08-26
EP0706394B1 (de)	2003-05-21
DE69432703T2 (de)	2004-03-25
ES2199961T3 (es)	2004-03-01
JP3552168B2 (ja)	2004-08-11
EP0706394A4 (de)	2000-06-28
DE69432703D1 (de)	2003-06-26
CA2160779A1 (en)	1995-09-08
DK0706394T3 (da)	2003-09-22

Legal Events

Date

Code

Title

Description

2003-12-15

UEP

Publication of translation of european patent specification

Ref document number: 0706394

Country of ref document: EP

2010-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE177629T1 (de)	1999-04-15	Verwendung von 2-hydroxycarbonsäure oder deren derivaten enthaltende zusammensetzung zur linderung von wechseln nagelveränderungen
EP0068552A3 (de)	1984-03-28	Topisches mikrobizides Präparat
DK0541232T3 (da)	1995-09-04	Polyvinylalkohol i kombination med glyoxylerede vinylamidpolymerer som crepningsklæbemiddelpræparater
YU6393A (sh)	1996-10-09	Novi derivati amidina i njihovo dobijanje
NO984718L (no)	1998-12-09	Irreversible inhibitorer for tyrosin-kinaser
NO991731L (no)	1999-06-14	Lokalanestetika for utvortes bruk
DE69621104D1 (de)	2002-06-13	Verwendung einer ein Polymersystem enthaltenden Zubereitung
ATE8203T1 (de)	1984-07-15	Antineoplastische mittel auf basis von nicht oder nur geringfuegig irritierenden und/oder promovierenden diterpenalkoholen und derivaten davon und deren herstellung.
ATE40819T1 (de)	1989-03-15	4-vinylbenzoesaeure-derivate, ihre herstellung und verwendung als arzneimittel und ligande.
ES2140565T3 (es)	2000-03-01	Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES2131830T3 (es)	1999-08-01	Benzamidinas sustituidas, su preparacion y uso como medicamentos.
DE69432703D1 (de)	2003-06-26	Verwendung einer Zusammensetzung enthaltend Histaminphosphat zur Herstellung eines Medikaments zur topischen Behandlung von epithelialen Entzündungen oder Läsionen
GB1503675A (en)	1978-03-15	Compositions based on pyrimidine derivatives and their use in the treatment of viral infections
ATE135564T1 (de)	1996-04-15	Kosmetische oder dermatologische zusammensetzung in form einer öl-in-wasser dispersion, die verbundfilme bilden kann
ATE221780T1 (de)	2002-08-15	Fenbendazolformulierungen
ATE32071T1 (de)	1988-02-15	Cyclohexenonderivate, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ES2137196T3 (es)	1999-12-16	Formulacion antiseborreica.
MX9301723A (es)	1994-01-31	Derivados de carbinol di-arilo puenteados, composiciones y metodos de uso.
FI920425A0 (fi)	1992-01-30	Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
ATE85383T1 (de)	1993-02-15	Dachabdeckung.
GB1242863A (en)	1971-08-18	2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
ES2064958T3 (es)	1995-02-01	Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.
EP0356935A3 (de)	1991-04-03	Hemmung von HIV mittels Transformationswachstumsfaktor Beta
ES8200322A1 (es)	1981-11-01	Procedimiento para la obtencion de un gel a base de acido 2-(3-benzoilfenil)-propionico
ATE92063T1 (de)	1993-08-15	Verbrueckte bicyclische 4-(4-(3-benzisothiazolyl)1-piperazinyl)-butylimide mit antipsychotischer wirkung.